A phase II study to determine relapse-free interval after withdrawal of imatinib therapy in adult patients with chronic phase chronic myeloid leukaemia in stable complete molecular remission (CML08)
收藏数据链接：
官方服务：
资源简介：
HeSANDA 1.0.0
创建时间：
2023-06-08
